Earnings Alerts

China Mengniu Dairy Co (2319) Earnings: FY Revenue Misses Estimates at 88.67 Billion Yuan

  • Mengniu Dairy’s fiscal year revenue amounted to 88.67 billion yuan.
  • This revenue figure fell short of the estimated 89.91 billion yuan.
  • The company announced a final dividend of 50.9 RMB cents per share.
  • Analyst recommendations include 34 buy ratings and 5 hold ratings; there are no sell ratings.

A look at China Mengniu Dairy Co Smart Scores

FactorScoreMagnitude
Value2
Dividend2
Growth3
Resilience3
Momentum5
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysing the Smartkarma Smart Scores for China Mengniu Dairy Co, the company’s overall outlook appears positive with strong momentum and growth prospects. With a momentum score of 5, indicating a high level of positive investor sentiment and upward price trend, Mengniu Dairy Co is attracting significant attention in the market. The growth score of 3 suggests that the company is positioned for expansion and development, indicating a promising future ahead.

In terms of value and dividend, Mengniu Dairy Co scored a 2 for both factors, reflecting moderate performance in these areas. However, the company’s resilience score of 3 indicates a certain level of stability and ability to withstand challenges. Overall, China Mengniu Dairy Co seems to be well-positioned for future growth and value creation in the dairy products market.

Summary of Company Description:
### China Mengniu Dairy Company Limited, through its subsidiaries, manufactures and distributes quality dairy products in China. The principal products are liquid milk products, ice cream, and other dairy products, such as milk powder. The Company markets its products under its primary MENGNIU core brand. ###


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars